Literature DB >> 16206978

Surfactant poloxamer 188-related decreases in inflammation and tissue damage after experimental brain injury in rats.

Daniel J Curry1, David A Wright, Raphael C Lee, Un Jung Kang, David M Frim.   

Abstract

OBJECT: The surfactant, poloxamer 188 (P-188), has been found to protect against tissue injury in various experimental models. Its protective mechanism may involve the effects of the surfactant against oxidative stress and inflammation. The authors investigated the role of P- 188 in the reduction of tissue injury and macrophage response in a model of excitotoxic brain injury in the rat striatum.
METHODS: Fifteen Sprague-Dawley rats underwent stereotactic injection of 120 nmol of quinolinic acid into the striatum and received intracisternal injection of vehicle or P-188 (40 mg/kg) at 10 minutes and 4 hours postinjury. Rats were killed after 1 week, and the histological score was determined based on the degree of overall tissue injury (Grades 1-4) at the lesion site. The number of macrophages within the lesioned striatum was compared with that found within the striatum on the nonoperated contralateral side. The scores related to tissue damage and the macrophage ratios of each group were then compared using t-tests. Striatal injection of the toxin produced a lesion characterized by necrosis and inflammation surrounding the injection site in all six control animals. In rats in which intracisternal P-188 was administered, significantly less tissue injury was demonstrated (mean score 2.45 +/- 0.74) than in controls (mean score 3.14 +/- 0.75) (p = 0.045). The rats that received intracisternal surfactant also had significantly less macrophage infiltrate (mean ratio 1.06 +/- 0.18) than control animals (mean ratio 2.00 +/- 0.48) (p = 0.004).
CONCLUSIONS: The surfactant P-188 reduces tissue loss and macrophage infiltrate after excitotoxic brain injury in the rat. Possible mechanisms of this effect may include direct surfactant modulation of inflammatory cell membrane fluidity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 16206978     DOI: 10.3171/ped.2004.101.2.0091

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  11 in total

1.  Mode of action of poloxamer-based surfactants in wound care and efficacy on biofilms.

Authors:  Steven L Percival; Rui Chen; Dieter Mayer; Anne-Marie Salisbury
Journal:  Int Wound J       Date:  2018-06-05       Impact factor: 3.315

2.  Tc-99m pyrophosphate imaging of poloxamer-treated electroporated skeletal muscle in an in vivo rat model.

Authors:  Kenneth L Matthews; John N Aarsvold; Robert A Mintzer; Chin-Tu Chen; Raphael C Lee
Journal:  Burns       Date:  2006-07-11       Impact factor: 2.744

3.  Poloxamer-188 attenuates TBI-induced blood-brain barrier damage leading to decreased brain edema and reduced cellular death.

Authors:  Hai-Jun Bao; Tao Wang; Ming-Yang Zhang; Ran Liu; Ding-Kun Dai; Yao-Qi Wang; Long Wang; Lu Zhang; Yu-Zhen Gao; Zheng-Hong Qin; Xi-Ping Chen; Lu-Yang Tao
Journal:  Neurochem Res       Date:  2012-09-26       Impact factor: 3.996

4.  Therapy development for diffuse axonal injury.

Authors:  Douglas H Smith; Ramona Hicks; John T Povlishock
Journal:  J Neurotrauma       Date:  2013-02-14       Impact factor: 5.269

5.  Electrodelivery of drugs into cancer cells in the presence of poloxamer 188.

Authors:  Iana Tsoneva; Iordan Iordanov; Annette J Berger; Toma Tomov; Biliana Nikolova; Nikola Mudrov; Martin R Berger
Journal:  J Biomed Biotechnol       Date:  2010-07-25

6.  Efficacy of a new multifunctional surfactant-based biomaterial dressing with 1% silver sulphadiazine in chronic wounds.

Authors:  Christoph Zölß; Jürgen D Cech
Journal:  Int Wound J       Date:  2014-09-08       Impact factor: 3.315

7.  Neurogenic and neuro-protective potential of a novel subpopulation of peripheral blood-derived CD133+ ABCG2+CXCR4+ mesenchymal stem cells: development of autologous cell-based therapeutics for traumatic brain injury.

Authors:  Joan E Nichols; Jean A Niles; Douglas DeWitt; Donald Prough; Margaret Parsley; Stephanie Vega; Andrea Cantu; Eric Lee; Joaquin Cortiella
Journal:  Stem Cell Res Ther       Date:  2013-01-06       Impact factor: 6.832

8.  Differential effects of commercial-grade and purified poloxamer 188 on renal function.

Authors:  Martin Emanuele; Balu Balasubramaniam
Journal:  Drugs R D       Date:  2014-06

9.  Dual Asymmetric Centrifugation Efficiently Produces a Poloxamer-Based Nanoemulsion Gel for Topical Delivery of Pirfenidone.

Authors:  Eugene P Chung; Adrienne R Wells; Mia Mae Kiamco; Kai P Leung
Journal:  AAPS PharmSciTech       Date:  2020-10-02       Impact factor: 3.246

Review 10.  Traumatic axonal injury (TAI): definitions, pathophysiology and imaging-a narrative review.

Authors:  Gavin F Bruggeman; Iain K Haitsma; Clemens M F Dirven; Victor Volovici
Journal:  Acta Neurochir (Wien)       Date:  2020-10-02       Impact factor: 2.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.